KLF4 Knockdown Attenuates TBI-Induced Neuronal Damage through p53 and JAK-STAT3 Signaling

Da-Ming Cui1, Tao Zeng1, Jie Ren1

  • 1Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Abstract

Insights

Blocking Kruppel-like factor 4 (KLF4) may treat traumatic brain injury (TBI). KLF4 knockdown in rats reduced neuronal damage and improved axon regeneration, suggesting KLF4 is a therapeutic target for TBI.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Regenerative Medicine

Background:

  • Traumatic brain injury (TBI) involves complex mechanisms leading to neuronal death and dysfunction.
  • Reactive oxygen species (ROS) contribute significantly to TBI-induced neuronal apoptosis.
  • Kruppel-like factor 4 (KLF4) is known to inhibit axon regeneration in other contexts but its role in TBI is unexplored.

Purpose of the Study:

  • To investigate the role of KLF4 in neuronal damage and repair following TBI.
  • To determine if KLF4 inhibition can mitigate TBI-induced pathology.
  • To elucidate the molecular pathways (p53, JAK-STAT3) involved in KLF4's function in TBI.

Main Methods:

  • Utilized hydrogen peroxide (H2O2)-treated retinal ganglion cells (RGCs) in vitro to model oxidative stress.
  • Employed an optic nerve crush model in vivo to assess RGC axon regeneration.
  • Investigated the impact of KLF4 knockdown on neuronal survival and damage in a rat model of moderate TBI.

Main Results:

  • H2O2 induced p53-dependent apoptosis in RGCs via KLF4 upregulation.
  • KLF4 knockdown enhanced nerve growth factor (CNTF)-induced axon regeneration post-optic nerve crush.
  • KLF4 knockdown significantly reduced neuronal damage following experimental TBI in rats, mediated by p53 and JAK-STAT3 pathways.

Conclusions:

  • KLF4 plays a critical role in the pathological processes of TBI.
  • Targeting KLF4 presents a promising therapeutic strategy for TBI treatment.
  • Combined therapies involving KLF4 blockade may offer enhanced efficacy for TBI recovery.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K